Elequin Capital’s Tevogen Bio Holdings TVGN Stock Holding History

Elequin Capital’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-148	Closed	-$76.3K	–	550
2022 Q4	$76.3K	Sell	148 -362	-71%	-$185K	0.02%	277
2022 Q3	$259K	Buy	510 +10	+2%	+$5.04K	0.1%	84
2022 Q2	$250K	Buy	+500	New	+$250K	0.06%	92

Other funds holding TVGN

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Elequin Capital's TVGN Position: Q1 2023 in Review

Elequin Capital sold out of Tevogen Bio Holdings (TVGN) in Q1 2023, closing a stake of 148 shares — an estimated $76.3K sold.

Elequin Capital first reported a position in TVGN in Q2 2022 and held it in 3 quarters. The position peaked at $259K in Q3 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

Elequin Capital reported no remaining Tevogen Bio Holdings position as of Q1 2023 after selling out during the quarter.
Elequin Capital sold 148 Tevogen Bio Holdings shares in Q1 2023, an estimated $76.3K.
Elequin Capital first reported a position in Tevogen Bio Holdings in Q2 2022 and held it in 3 quarters.
Elequin Capital's Tevogen Bio Holdings position peaked at $259K in Q3 2022.
4 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2023.

Based on Elequin Capital's 13F filing for Q1 2023, filed 11 May 2023.